There are currently 58 active clinical trials seeking participants for Cognitive Impairment research studies. The states with the highest number of trials for Cognitive Impairment participants are California, Florida, Illinois and New York.
Pacific Northwest Udall Center (PANUC) Clinical Core
Recruiting
This study evaluates cognitive impairment in subjects with Parkinson disease (PD) and similar neurological disorder through obtaining longitudinal clinical and neuropsychological data. The long term goal is to have a well-characterized subject population to contribute to our understanding of the natural history, diagnosis and ultimate treatment of cognitive impairment in patients with PD and similar disorders.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/11/2024
Locations: VA Puget Sound Health Care System, Seattle, Washington
Conditions: Parkinson Disease, Cognitive Impairment
Cognitive Screening Made Easy for PCPs - R33 Phase
Recruiting
This project will facilitate early detection of cognitive decline in older adults through development and implementation of an automated risk assessment and cognitive screening tool for use in primary care. By providing an automated tool developed specifically to address the needs of PCPs, it will be easier to screen for cognitive impairment, increasing the number of older adults who are screened and thus identified and treated.
Gender:
ALL
Ages:
60 years and above
Trial Updated:
04/23/2024
Locations: Family Wellness Clinic, Austin, Texas
Conditions: Cognitive Impairment, Dementia, Mild, Cognitive Decline
Brain Health in Breast Cancer Survivors
Recruiting
Endocrine therapy (ET) is widely used to treat hormone receptor positive breast cancer and prevent recurrence by downregulating estrogen function. However, ETs readily cross the blood brain barrier and interfere with the action of estrogen in the brain. Estrogen supports cognition and menopausal status is closely linked to cognitive health in women. This has raised concern that anti-estrogen ETs may affect cognition and brain health in breast cancer survivors. However, evidence across existing s... Read More
Gender:
FEMALE
Ages:
Between 35 years and 65 years
Trial Updated:
04/12/2024
Locations: University of California at Los Angeles, Los Angeles, California
Conditions: Cognitive Impairment, Cognitive Function
Cognitive Training Intervention and Attitudes Towards Genetics
Recruiting
A pilot study to evaluate feasibility of enrollment of patients in an intervention to improve neurocognitive function in hematopoietic cell transplantation (HCT) survivors using the cognitive training Lumosity program. In addition, patients' interest in receiving information regarding genetic risk of cognitive impairment post-HCT will be measured.
Gender:
ALL
Ages:
21 years and above
Trial Updated:
04/08/2024
Locations: University of Alabama at Birmingham, Birmingham, Alabama
Conditions: Cognitive Impairment, Hematologic Neoplasms, Hematopoietic Cell Transplant
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
Recruiting
The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons with walking disability due to Multiple Sclerosis. The study will evaluate the mobility, learning and memory, and walking abilities of individuals with multiple sclerosis who went through the traditional as compared to others who used the robotic exoskeleton as part of their therapy.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
04/01/2024
Locations: Kessler Foundation, West Orange, New Jersey
Conditions: Multiple Sclerosis, Gait Disorders, Neurologic, Motility Disorder, Cognitive Impairment
Amygdala Memory Enhancement
Recruiting
The objective is to understand how amygdala activation affects other medial temporal lobe structures to prioritize long-term memories. The project is relevant to disorders of memory and to disorders involving affect and memory, including traumatic brain injury and post-traumatic stress disorder.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
03/11/2024
Locations: Washington University School of Medicine, Saint Louis, Missouri
Conditions: Brain Diseases, Epilepsy, Memory Disorders, Traumatic Brain Injury, Cognitive Impairment, Post Traumatic Stress Disorder
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
Recruiting
The purpose of this research study is to see how the brain changes in patients receiving chemotherapy (cytotoxic drug) treatment for colon or rectal cancer at Parkview Cancer Institute. This information will be used to identify helpful tests to diagnose individuals at risk for developing difficulties with thinking and memory due to their cancer treatments.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
11/14/2023
Locations: Parkview Cancer Institute, Fort Wayne, Indiana
Conditions: Neoplasm, Colorectal, Cognitive Impairment, Cognitive Dysfunction, Cognitive Change, Chemo-brain, Chemo Fog, Chemotherapy Effect, Cognitive Decline
Influence of Cognition on Activity and Participation in People With Stroke
Recruiting
If a subject agrees to participate, the primary investigators will collect some basic information including age, height, and weight. Intake of some general questions regarding health will be performed and each subject will complete some tests that measure walking speed, cognition, and balance. During these tests participants will be asked to stand from a chair, walk up \& down a staircase, walk over objects in a forward, backward, and sideways directions, walk around objects in forward and backw... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/15/2023
Locations: Saint Joseph's University, Philadelphia, Pennsylvania
Conditions: Stroke, Cognitive Change, Neurological Injury, Cognitive Impairment, Activity, Motor
SPARK Neuro REMIND Study
Recruiting
The study utilizes investigational software, the SPARK Test, with an FDA-cleared electroencephalography (EEG) amplifier and EEG cap to collect and then analyze patient EEG data.
Gender:
ALL
Ages:
Between 55 years and 85 years
Trial Updated:
07/06/2022
Locations: Voyage Medical, Tempe, Arizona
Conditions: Alzheimer Disease, Cognitive Impairment
Cognition and the Immunology of Postoperative Outcomes
Recruiting
This research will test the hypothesis that immune system disequilibrium / dysfunction explains why preoperative cognitive impairment is a strong predictor of postoperative morbidity in older surgical patients. The investigators propose that cognitive impairment influences surgical morbidity because of underlying immune disequilibrium / dysfunction (risk marker) and that this shapes the immune response to surgery and defines immunological hallmarks of postoperative morbidity (disease marker). Th... Read More
Gender:
ALL
Ages:
65 years and above
Trial Updated:
03/10/2021
Locations: Brigham & Women's Hospital, Boston, Massachusetts
Conditions: Cognitive Impairment, Frail Elderly Syndrome, Delirium, Surgery